Jobs / United States / Astrazeneca Pharmaceuticals Lp
Global Study Associate Director
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Durham - NC
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Job Title: Global Study Associate Director Location: Durham, NC Introduction to role: Are you ready to lead global clinical studies that turn cutting-edge science into evidence that changes patients’ lives? In this role, you will own the end-to-end delivery of complex studies, guiding cross-functional teams and external partners from handover to close-out and archiving, so our medicines can reach those who need them faster. You will operate at the center of study execution—aligning strategy with action, translating risk into robust plans, and making data-driven decisions that safeguard quality, timelines, and budget. Working with knowns and unknowns, you will champion clarity, pace, and accountability while shaping how we use digital, data, and technology to advance clinical development. What could you accomplish by uniting diverse experts around a clear plan—and keeping a global study inspection-ready, on budget, and ahead of schedule? Accountabilities: • Study Leadership and Delivery: Lead and empower a cross-functional study team and/or oversee outsourced partners to deliver against agreed timelines, budget, and quality standards; hold accountability for one or several studies and drive milestone achievement. • Cross-Functional and External Communication: Orchestrate clear, timely communication across functions and vendors; plan and lead investigator meetings and key study forums to maintain alignment and momentum. • Study Documentation Ownership: Provide input to and hold accountability for essential study documents from Clinical Study Protocol through Clinical Study Report in line with SOPs and regulatory requirements. • Vendor Strategy and Oversight: Ensure CROs and other vendors (e.g., central labs, IXRS, ePRO) deliver to contract, timeline, and budget; document oversight, escalate issues, and support vendor selection when needed. • Quality and Risk Management: Build and maintain risk-based quality plans, proactive risk and contingency strategies, and clear escalation pathways; champion a culture of issue prevention and rapid resolution. • Data and Systems Integrity: Ensure accuracy and currency of study-level systems (e.g., ACCORD/ABACUS, PharmaCM); use operational data to drive decisions and transparency. • Performance and KPI Management: Monitor operational and quality KPIs, track progress against plans, and communicate risks, mitigations, and impacts to study leadership and the Clinical Program Team. • Issue Management and CAPA: Identify, report, and resolve quality issues; coordinate corrective and preventive actions with stakeholders and communicate outcomes to CPT, QA, and functional leaders. • Trial Master File Excellence: Oversee TMF strategy, plan, and Expected Document List; ensure ongoing QC and continuous inspection readiness. • Compliance and Governance: Secure timely compliance with governance controls (e.g., Delegation of Authority, Sunshine Act, clinical trial transparency) and uphold ICH-GCP, SOPs, policies, and best practices. • Budget Ownership: Re-forecast and manage the study budget throughout the lifecycle; provide clear budget status, risks, and mitigations to the CPT and drive disciplined change control. • Inspection Readiness: Serve as the primary Study Management point-of-contact during audits or inspections; maintain a constant state of readiness with robust documentation and processes. • People Development and Mentoring: Provide ongoing feedback to team members and line managers; mentor less experienced colleagues to build capability across the organization. • Continuous Improvement and SME Contributions: Lead or contribute to non-drug project work, process enhancements, and act as a subject matter expert for Study Management systems or processes. Essential Skills/Experience: •